` MOLN (Molecular Partners AG) vs S&P 500 Comparison - Alpha Spread

MOLN
vs
S&P 500

Over the past 12 months, MOLN has underperformed S&P 500, delivering a return of -21% compared to the S&P 500's +15% growth.

Stocks Performance
MOLN vs S&P 500

Loading
MOLN
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MOLN vs S&P 500

Loading
MOLN
S&P 500
Difference
www.alphaspread.com

Performance By Year
MOLN vs S&P 500

Loading
MOLN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Molecular Partners AG vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Molecular Partners AG
Glance View

Market Cap
136m USD
Industry
Biotechnology

Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 163 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

MOLN Intrinsic Value
9.67 USD
Undervaluation 58%
Intrinsic Value
Price
Back to Top